(Q45398545)

English

Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus

scientific article published on 3 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Simian immunodeficiency virus

0 references

Semliki Forest virus

0 references

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

6

object named as

Bruno Vaslin

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Frédéric Martinon

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Patricia Brochard

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Maryline Ripaux

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Benoît Delache

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gwenaelle Aurégan

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Roger Le Grand

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

3 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

532-545

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Macaque models for AIDS vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Assessing animal models of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8(+) T-cell response in mucosal tissues during SIV primary infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Sustained conservation of CD4+ T cells in multiprotein triple modality-immunized rhesus macaques after intrarectal challenge with simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.11.025

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

release_kdfsfj6qczcofmu7caj74n7ifu

1 reference

https://api.fatcat.wiki/v0/release/kdfsfj6qczcofmu7caj74n7ifu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45398545&oldid=2076578454"